---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-001553"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T08:48:27.662148+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA reports Gilead support for potential Poolbeg acquisition; fundraise revised to $30M+ primary placement

## Summary
- Gilead, owning 19.4% of HOOKIPA shares, signals intent to vote for the deal and join the $30M+ fundraise.
- HOOKIPA revised fundraise to ~$30M+ primary private placement (previously up to ~$30M).
- Oppenheimer & Co. Inc. engaged as placement agent for the private placement fundraise.
- Discussions remain non-binding; no assurance a firm offer will be made or deal completed.

## SEC filing metadata
- accession: 0001104659-25-001553
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465925001553/0001104659-25-001553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465925001553/tm252116d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-001553
- JSON: https://secwatch.observer/filing/0001104659-25-001553.json
- Plain text: https://secwatch.observer/filing/0001104659-25-001553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.